Herceptin "Linked To Heart Risk" Published: Aug 15, 2006 Roche Holding AG's (RHHBY) breast cancer drug Herceptin increases the risk of cardiac toxicity, but the majority of this heart damage can be reversed with treatment, a new study, published Monday, showed. >>> Discuss This Story Related links BBC News This will open in a new window San Jose Mercury News This will open in a new window Market Watch This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news